FINANCIAL TRUST COMPANY For the INC ACCT. W23580001 Period 1/1/12 to 1/31/12 Trade Date Per Unit Settle Date Type Description Quantity Amount Market Cost Settled Securities Purchased 1/20 Purchase BOARDWALK PIPELINE PARTNERS II 27.55 J.P. MORGAN 1,250.000 27.55 (34,437.50) 1/25 SECURITIES LLC (ID: 098627-10-4) 1/20 Purchase ZIOPHARM ONCOLOGY INC GI 5.20 J.P. MORGAN 8,750.000 5.20 (35,100.00) 1/25 SECURITIES LLC (ID: 98973P-10-1) 1/25 Purchase ENTRY REVERSED ON 02/02/2012 GUIDEWIRE SOFTWARE 375.000 13.00 (4,875.00) 1/30 INC ei 13.00 J.P. MORGAN SECURITIES LLC (ID: 40171V-10-0) 1/25 Purchase WILLIAMS PARTNERS LP 0 62.81 J.P. MORGAN 3,000.000 62.81 (188,430.00) 1/30 SECURITIES LLC (ID: 98950E-10-4) 1/28 Purchase REPUBLIC OF ARGENTINA NOTES DEC 15 2035 DTD 7.500.000.000 13.90 (1.038.750.00) 1/31 11/01/2005 HELD BY EUROCLEAR ISIN US040114GM64 SEDOL BOS5NO3 (ID: 042993-9S-6) 1124 Purchase AEGON NV 8% PFD @ 25.00 J.P. MORGAN SECURITIES 20.000.000 25.00 (500.000.00) 1/31 LLC (ID: 007924-60-8) Total Settled Securities Purchased (54,294,685.76) Trade Dale Type Per Unit Realized Est. Settle Date Selection Method Description Quantity Amount Proceeds Tax Cost Gaintoss Pending Sales. Maturities. Redemptions 1/27 Sale FRANCESCAS HOLDINGS CORP (ID. 351793-10-4) (3,150.003) 23.15 72,764.08 (72,450.00) 314.06 S 2/1 1131 Sale FIRST REPUBLIC BANKiSF 6.7% PFD (30,500 000) 25.072 763,175.22 (762,500.00) 675.22 S 2/3 (ID: 33616C-20-9) Total Pending Sales, Maturities, Redemptions $835,939.28 ($834,950.00) 5989.28 S J.P.Morgan Account tb23550001 Page 22 of 27 Consolidated Statement Page 25 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-000 15553 SDNY_GM_00284751 EFTA01492742